466 related articles for article (PubMed ID: 26931513)
21. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.
Wellenstein MD; de Visser KE
Immunity; 2018 Mar; 48(3):399-416. PubMed ID: 29562192
[TBL] [Abstract][Full Text] [Related]
22. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response.
Gilabert-Oriol R; Ryan GM; Leung AWY; Firmino NS; Bennewith KL; Bally MB
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261606
[TBL] [Abstract][Full Text] [Related]
23. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment.
Pitt JM; Kroemer G; Zitvogel L
Adv Exp Med Biol; 2017; 1036():65-79. PubMed ID: 29275465
[TBL] [Abstract][Full Text] [Related]
24. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.
Di Mitri D; Alimonti A
Trends Cell Biol; 2016 Mar; 26(3):215-226. PubMed ID: 26564316
[TBL] [Abstract][Full Text] [Related]
25. Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer.
Trivedi S; Rosen CA; Ferris RL
Curr Opin Otolaryngol Head Neck Surg; 2016 Apr; 24(2):121-7. PubMed ID: 26963671
[TBL] [Abstract][Full Text] [Related]
26. Myeloid derived-suppressor cells: their role in cancer and obesity.
Ostrand-Rosenberg S
Curr Opin Immunol; 2018 Apr; 51():68-75. PubMed ID: 29544121
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic senescence: a multi-functional perspective.
Baker DJ; Alimirah F; van Deursen JM; Campisi J; Hildesheim J
Oncotarget; 2017 Apr; 8(16):27661-27672. PubMed ID: 28416761
[TBL] [Abstract][Full Text] [Related]
28. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
29. Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota.
Morgillo F; Dallio M; Della Corte CM; Gravina AG; Viscardi G; Loguercio C; Ciardiello F; Federico A
Neoplasia; 2018 Jul; 20(7):721-733. PubMed ID: 29859426
[No Abstract] [Full Text] [Related]
30. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
31. Role of Local Radiation Therapy in Cancer Immunotherapy.
Demaria S; Golden EB; Formenti SC
JAMA Oncol; 2015 Dec; 1(9):1325-32. PubMed ID: 26270858
[TBL] [Abstract][Full Text] [Related]
32. Immune Regulation and Antitumor Effect of TIM-1.
Du P; Xiong R; Li X; Jiang J
J Immunol Res; 2016; 2016():8605134. PubMed ID: 27413764
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
Frey B; Rückert M; Deloch L; Rühle PF; Derer A; Fietkau R; Gaipl US
Immunol Rev; 2017 Nov; 280(1):231-248. PubMed ID: 29027224
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
35. The role of senescence in cancer development.
Mavrogonatou E; Pratsinis H; Kletsas D
Semin Cancer Biol; 2020 May; 62():182-191. PubMed ID: 31260734
[TBL] [Abstract][Full Text] [Related]
36. Phytomedicine-Modulating oxidative stress and the tumor microenvironment for cancer therapy.
Cheng YT; Yang CC; Shyur LF
Pharmacol Res; 2016 Dec; 114():128-143. PubMed ID: 27794498
[TBL] [Abstract][Full Text] [Related]
37. The colorectal cancer immune microenvironment and approach to immunotherapies.
Koi M; Carethers JM
Future Oncol; 2017 Aug; 13(18):1633-1647. PubMed ID: 28829193
[No Abstract] [Full Text] [Related]
38. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.
Menon H; Ramapriyan R; Cushman TR; Verma V; Kim HH; Schoenhals JE; Atalar C; Selek U; Chun SG; Chang JY; Barsoumian HB; Nguyen QN; Altan M; Cortez MA; Hahn SM; Welsh JW
Front Immunol; 2019; 10():193. PubMed ID: 30828330
[TBL] [Abstract][Full Text] [Related]
39. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.
Lu B; Yang M; Wang Q
J Mol Med (Berl); 2016 May; 94(5):535-43. PubMed ID: 26922618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
